Fortrea Holdings FTRE
NASDAQ FTRE
$20.29 +0.32 (+1.60%)
As of: Sep 17, 2026 · 3:59 PM EDT

Fortrea Holdings (FTRE) Cash from Operations (2022 - 2026)

Fortrea Holdings' (FTRE) quarterly Cash from Operations came in at $28.9 million in Q2 2026, up 32.57% on a YoY basis from $21.8 million in Q2 2025, and up 270.0% quarter-over-quarter from -$17.0 million in Q1 2026.

Analysis

Fortrea Holdings (FTRE) Cash from Operations (2022 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has reported Cash from Operations for 5 consecutive years, with $28.9 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Cash from Operations rose 32.57% year-over-year to $28.9 million; the trailing twelve-month figure through Jun 2026 stood at $227.8 million (up 359.75% YoY), and the FY2025 full-year result was $113.5 million, down 56.81% from the prior year.
  • Cash from Operations climbed to $28.9 million in Q2 2026 per FTRE's latest filing, from -$17.0 million in the prior quarter.
  • Across five years, Cash from Operations topped out at $273.7 million in Q2 2024 and bottomed at -$124.2 million in Q1 2025.
  • Historically, Cash from Operations has averaged $41.3 million across 5 years, with a median of $20.1 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Cash from Operations slumped 1180.0% in 2024, then soared 3716.67% in 2025.
  • Over 5 years, Cash from Operations stood at $23.5 million in 2022, then decreased by 21.7% to $18.4 million in 2023, then dropped by 7.07% to $17.1 million in 2024, then jumped by 654.97% to $129.1 million in 2025, then plunged by 77.61% to $28.9 million in 2026.
  • According to Business Quant data, Cash from Operations over the past three periods registered $28.9 million, -$17.0 million, and $129.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 558.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 162.01 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 281.27 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 179.73 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 28.90 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -44.27 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -492,000.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -2.90 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - -3.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 28.90 Mn
Mar 31, 2026 -17.00 Mn
Dec 31, 2025 129.10 Mn
Sep 30, 2025 86.80 Mn
Jun 30, 2025 21.80 Mn
Mar 31, 2025 -124.20 Mn
Dec 31, 2024 17.10 Mn
Sep 30, 2024 -2.40 Mn
Jun 30, 2024 273.70 Mn
Mar 31, 2024 -25.60 Mn
Dec 31, 2023 18.40 Mn
Sep 30, 2023 1.90 Mn
Jun 30, 2023 150.10 Mn
Mar 31, 2023 -2.00 Mn
Dec 31, 2022 23.50 Mn
Sep 30, 2022 80.90 Mn